Table 2.
Clinical results of non-stable patients (group 2).
| # | Sex | Age (years) | Medical Status at Initial Evaluation * | Laboratory Abnormalities at Re-Evaluation | CLD Complications at Re-Evaluation | Long-Term Medical Outcome |
|---|---|---|---|---|---|---|
| 1 | M | 13 | Ideal | TB | - | Non-ideal |
| 2 | M | 10 | Ideal | TB | - | Non-ideal |
| 3 | M | 12 | Ideal | TB | Cholangitis | Non-ideal |
| 4 | M | 5 | Ideal | ALT, PLT | - | Non-ideal |
| 5 | F | 14 | Ideal | TB | Cholangitis | Non-ideal |
| 6 | F | 6 | Ideal | WBC | - | Non-ideal |
| 7 | M | 6 | Non-ideal a | TB, PLT | Portal hypertension | Clinical progression |
| 8 | M | 5 | Non-ideal b | WBC | - | Clinical progression |
| 9 | F | 7 | Non-ideal c | AST, ALT, WBC, | - | Clinical progression |
| 10 | F | 10 | Non-ideal d | TB | - | Clinical progression |
| 11 | M | 7 | Non-ideal e | WBC | - | Clinical progression |
| 12 | F | 7 | Non-ideal f | TB | - | Clinical progression |
* The medical status was established according to the criteria of Ng et al. [23] and Lee et al. [18]. ° Abnormal values out of the normal range. - = not present. a Increased values of AST and ALT associated with the presence of cholangitis; b decreased values of PLT associated with the presence of portal hypertension; c decreased values of PLT associated with the presence of cholangitis and portal hypertension; d abnormal values of PLT and INR associated with the presence of cholangitis, portal hypertension, and variceal bleeding; e abnormal values of AST, ALT, GGT, and PLT associated with the presence of portal hypertension; f abnormal values of AST, ALT, INR, albumin, WBC, and PLT associated with the presence of cholangitis and portal hypertension.